One of the main players in apoptosis during Alzheimer’s disease progression are different members of caspase family of proteases. The most well-known member of this family is caspase-3, in which alterations of its levels have been detected in samples from Alzheimer’s disease patients. There are numerous intracellular factors involved in regulation of cellular apoptosis through regulation of caspase-3 activity, the most important of which is the PI3K/AKT signaling pathway. This commentary tries to highlight the probable relations between PI3K/AKT signaling pathway and caspase-3 in Alzheimer’s disease.
BhatiaV, SharmaS (2021) Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer’s disease. J Neurol Sci421, 117253.
2.
JembrekMJ, SladeN, HofPR, SimićG (2018) The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease. Prog Neurobiol168, 104–127.
3.
Van OpdenboschN, LamkanfiM (2019) Caspases in cell death, inflammation, and disease. Immunity50, 1352–1364.
4.
Van GorpH, Van OpdenboschN, LamkanfiM (2019) Inflammasome-dependent cytokines at the crossroads of health and autoinflammatory disease. Cold Spring Harbor Perspect Biol11, a028563.
LounevaN, CohenJW, HanL-Y, TalbotK, WilsonRS, BennettDA, TrojanowskiJQ, ArnoldSE (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer’s disease. Am J Pathol173, 1488–1495.
7.
WangC, HaoJ, LiuX, LiC, YuanX, LeeRJ, BaiT, WangD (2020) Isoforsythiaside attenuates Alzheimer’s disease via regulating mitochondrial function through the PI3K/AKT pathway. Int J Mol Sci21, 5687.
8.
LongH-Z, ChengY, ZhouZ-W, LuoH-Y, WenD-D, GaoL-C (2021) PI3K/AKT signal pathway: A target of natural products in the prevention and treatment of Alzheimer’s disease and Parkinson’s disease. Front Pharmacol12, 648636.
9.
KhezriMR, Ghasemnejad-BerenjiM (2023) The role of caspases in Alzheimer’s disease: Pathophysiology implications and pharmacologic modulation. J Alzheimers Dis91, 71–90.
10.
RickleA, BogdanovicN, VolkmanI, WinbladB, RavidR, CowburnRF (2004) Akt activity in Alzheimer’s disease and other neurodegenerative disorders. Neuroreport15, 955–959.
11.
Jahani-AslA, BasakA, TsangBK (2007) Caspase-3-mediated cleavage of Akt: Involvement of non-consensus sites and influence of phosphorylation. FEBS Lett581, 2883–2888.
12.
ChuJ, LaurettiE, PraticòD (2017) Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: Implications for Alzheimer’s disease. Mol Psychiatry22, 1002–1008.
13.
KhezriMR, YousefiK, EsmaeiliA, Ghasemnejad-BerenjiM (2023) The role of ERK1/2 pathway in the pathophysiology of Alzheimer’s disease: An overview and update on new developments. Cell Mol Neurobiol43, 177–191.
14.
BenedictusMR, LeeuwisAE, BinnewijzendMA, KuijerJ, ScheltensP, BarkhofF, van der FlierWM, PrinsND (2017) Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease. Eur Radiol27, 1169–1175.
15.
DaulatzaiMA (2010) Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer’s disease. J Alzheimers Dis20, 355–367.
16.
HuBR, LiuCL, OuyangY, BlomgrenK, SiesjöBK (2000) Involvement of caspase-3 in cell death after hypoxia–ischemia declines during brain maturation. J Cereb Blood Flow Metab20, 1294–1300.
17.
SankarSB, PybusAF, LiewA, SandersB, ShahKJ, WoodLB, BuckleyEM (2019) Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury. Neurobiol Dis124, 544–554.
18.
d’AmelioM, CavallucciV, MiddeiS, MarchettiC, PacioniS, FerriA, DiamantiniA, De ZioD, CarraraP, BattistiniL (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer’s disease. Nat Neurosci14, 69–76.
19.
Jarero-BasultoJJ, Luna-MuñozJ, MenaR, KristofikovaZ, RipovaD, PerryG, BinderLI, Garcia-SierraF (2013) Proteolytic cleavage of polymeric tau protein by caspase-3: Implications for Alzheimer disease. J Neuropathol Exp Neurol72, 1145–1161.
20.
BarnesNY, LiL, YoshikawaK, SchwartzLM, OppenheimRW, MilliganCE (1998) Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J Neurosci18, 5869–5880.
